Literature DB >> 26914565

Follicular Lymphoma Showing Avid Uptake on 68Ga PSMA-HBED-CC PET/CT.

Gowri L Kanthan1, Luke Coyle, Andrew Kneebone, Geoffrey Paul Schembri, Edward Hsiao.   

Abstract

Ga prostate-specific membrane antigen (PSMA) PET/CT is a new imaging technique that is significantly more sensitive to prostate cancer lesions than other conventional imaging modalities. Various other benign and malignant neoplasms may also express PSMA and show uptake on PSMA PET/CT scan. We report a case of 66-year-old man who had a PSMA PET/CT scan for restaging of prostate carcinoma. A PSMA-avid left femoral lymph node was identified. Subsequent biopsy confirmed the diagnosis of follicular lymphoma. It is important to be aware of this possibility to avoid scan misinterpretation. Biopsy of any atypical or clinically unexpected lesions should be considered.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26914565     DOI: 10.1097/RLU.0000000000001169

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  15 in total

1.  68Ga-Prostate-Specific Membrane Antigen, A Potential Radiopharmaceutical in PET/CT To detect primary Cholangiocarcinoma.

Authors:  Rita Chahinian; Ahmad El-Amine; Sayed Matar; Mostafa Annan; Ali Shamseddine; Mohamad Haidar
Journal:  Asia Ocean J Nucl Med Biol       Date:  2020

2.  Proposal for a Structured Reporting System for Prostate-Specific Membrane Antigen-Targeted PET Imaging: PSMA-RADS Version 1.0.

Authors:  Steven P Rowe; Kenneth J Pienta; Martin G Pomper; Michael A Gorin
Journal:  J Nucl Med       Date:  2017-09-08       Impact factor: 10.057

3.  [68Ga]Ga-PSMA-11 in prostate cancer: a comprehensive review.

Authors:  Frédéric Bois; Camille Noirot; Sébastien Dietemann; Ismini C Mainta; Thomas Zilli; Valentina Garibotto; Martin A Walter
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-12-15

4.  Cancers and Benign Processes on 68 Ga PSMA PET-CT Imaging Other than Prostate Cancer.

Authors:  Pinar Pelin Ozcan; Mustafa Serdengectı; Zehra Pinar Koc; Yüksel Balcı; Mesut Tek; Murat Bozlu; Erdem Akbay; Vehbi Erçolak
Journal:  World J Nucl Med       Date:  2022-07-05

Review 5.  Targeting PSMA by radioligands in non-prostate disease-current status and future perspectives.

Authors:  Philipp Backhaus; Benjamin Noto; Nemanja Avramovic; Lena Sophie Grubert; Sebastian Huss; Martin Bögemann; Lars Stegger; Matthias Weckesser; Michael Schäfers; Kambiz Rahbar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-01-15       Impact factor: 9.236

Review 6.  Pearls and pitfalls in clinical interpretation of prostate-specific membrane antigen (PSMA)-targeted PET imaging.

Authors:  Sara Sheikhbahaei; Ali Afshar-Oromieh; Matthias Eiber; Lilja B Solnes; Mehrbod S Javadi; Ashley E Ross; Kenneth J Pienta; Mohamad E Allaf; Uwe Haberkorn; Martin G Pomper; Michael A Gorin; Steven P Rowe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-01       Impact factor: 9.236

7.  Incidental prostate-specific membrane antigen-avid glioblastoma detected on 68Ga-prostate-specific membrane antigen PET/CT.

Authors:  James Yuheng Jiang; Christine Kang; Paul Bui; Robert Mansberg
Journal:  Radiol Case Rep       Date:  2022-04-08

8.  Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the block.

Authors:  Ansje S Fortuin; Roger Brüggemann; Janine van der Linden; Ilia Panfilov; Bas Israël; Tom W J Scheenen; Jelle O Barentsz
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-04-06

9.  Prostate-specific membrane antigen PET imaging and immunohistochemistry in adenoid cystic carcinoma-a preliminary analysis.

Authors:  Thomas J W Klein Nulent; Robert J J van Es; Gerard C Krijger; Remco de Bree; Stefan M Willems; Bart de Keizer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-07       Impact factor: 9.236

10.  Demonstration of 68Ga-prostate-specific Membrane Antigen Uptake in Metastatic Pancreatic Neuroendocrine Tumor.

Authors:  Meghana Prabhu; Nishikant Avinash Damle; Ravikant Gupta; Saurabh Arora; Sreedharan Thankarajan Arunraj; Chandrasekhar Bal
Journal:  Indian J Nucl Med       Date:  2018 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.